Showing results (1381-1390 of 1,423) with videos related to

Sort By:
Pageof 143
JCO Oncology Practice|May 9, 2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO GuidelineKimberly Perez, Jaydira Del Rivero, Erin B Kennedy, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 11, 2012
AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery, , , et al.
Journal of the American Academy of Dermatology|September 11, 2012
AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery, Suzanne M Connolly, Diane R Baker, et al.
Journal of the American College of Cardiology|May 31, 2023
Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver TransplantationMatthew J Lewis, Leigh C Reardon, Jamil Aboulhosn, et al.
Nature Medicine|October 19, 2023
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trialJason J Luke, Manish R Patel, George R Blumenschein, et al.
Journal of the American College of Cardiology|May 31, 2023
Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver TransplantationMatthew J Lewis, Leigh C Reardon, Jamil Aboulhosn, et al.
Human Mutation|March 26, 2014
Novel mutations widen the phenotypic spectrum of slow skeletal/β-cardiac myosin (MYH7) distal myopathyPhillipa J Lamont, William Wallefeld, David Hilton-Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)Sylvia Adams, Megan Othus, Sandip Pravin Patel, et al.
Clinical Breast Cancer|September 28, 2019
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022Rachel A Freedman, Rebecca S Gelman, Nathalie Y R Agar, et al.
Breast Cancer Research and Treatment|August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypesLauren Lenz, Chris Neff, Cara Solimeno, et al.
Pageof 143